Addex Therapeutics Ltd share price logo

Addex Therapeutics Ltd Share Price

NASDAQ: ADXN

Small Cap

$5.72

-0.56

(-8.93%)

as on

Addex Therapeutics Ltd Stock Performance

as on April 3, 2026 at 6:42 am IST

  • Day's High

    $5.72
    $6.46

    12.94%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.57
    $12.05
    downward going graph

    2.62%

    Downside

    110.66%

    Upside

    downward going graph

Addex Therapeutics Ltd share price movements today

Previous Close
$6.28
Open
$6.25
Volume
108.2K
Day's Low - High
$5.72 - $6.46
52 Week Low - High
$5.57 - $12.05

Addex Therapeutics Ltd Historical Returns

1 Month Return
-19.67 %
3 Month Return
-29.3 %
1 Year Return
-23.02 %
3 Year Return
-69.02 %
5 Year Return
-97.29 %

Addex Therapeutics Ltd Stock Fundamentals & Key Indicators

Check Addex Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.0M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-2.5M

Revenue (TTM)

158.5K

Profit Margin

0.00%

Return On Equity TTM

-72.84%

Addex Therapeutics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Addex Therapeutics Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Addex Therapeutics Ltd image
Addex Therapeutics Ltd
SELL$7.0M-97.29%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B124.84%136.858.45%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.7BNA125.835.37%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.4B105.93%28.6632.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.5B60.41%18.3831.41%

Stock Returns calculator for Addex Therapeutics Ltd Stock including INR - Dollar returns

The Addex Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Addex Therapeutics Ltd investment value today

Current value as on today

₹83,070

Returns

-₹16,930

(-16.93%)

Returns from Addex Therapeutics Ltd Stock

-₹23,015 (-23.01%)

Dollar Impact

₹6,085 (+6.09%)

Analyst Recommendation on Addex Therapeutics Ltd Stock

Based on 10 analysts

SELL

10.00%

Buy

20.00%

Hold

70.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'SELL' rating for Addex Therapeutics Ltd. Average target price of $30

Addex Therapeutics Ltd Share Price Target

Get share price movements and forecasts by analysts on Addex Therapeutics Ltd.

What analysts predicted

80.93%UPSIDE

Target Price

$30

Current Price

$5.72

Analyzed by

10 Analysts

Target

$30.00

Addex Therapeutics Ltd target price $30, a slight upside of 80.93% compared to current price of $5.72. According to 10 analysts rating.

Addex Therapeutics Ltd Stock’s Investor Sentiment and Interest

Search interest for Addex Therapeutics Ltd Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-18% versus previous 30 day period

Addex Therapeutics Ltd Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
-1
0
0
0
-
0
0
0
Operating Income
0
0
-2
0
0
0
0
0
0
0
EBITDA
0
0
-2
0
-1
-1
-
-1
-1
-1
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
-2
0
-1
-1
-1
-1
-1
-1
Income Tax Expense
0
0
0
3
-14
-
-
-
-
-
Net Income
-2
-2
-3
-3
14
-1
-1
-1
-1
-1
Net Profit Margin
-424.04%
-798.54%
-1861.73%
-1322.23%
11171.90%
-2841.86%
-79955.97%
-97669.96%
-5061.62%
-5306.25%

Addex Therapeutics Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
0
6
2
4
3
1
1
0
Gross Profit
0
0
0
5
2
4
3
1
1
0
Operating Income
-3
-3
-3
-1
-14
-12
-15
-10
-2
-2
EBITDA
-2
-3
-3
-1
-14
-12
-14
-10
-2
-4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-4
-3
-3
-1
-14
-12
-15
-10
-2
-4
Income Tax Expense
0
0
-
0
0
0
0
0
0
-
Net Income
-4
-3
-3
-1
-15
-14
-16
-22
-12
7
Net Profit Margin
-10432.03%
-18174.08%
-656.22%
-27.21%
-534.98%
-355.92%
-526.42%
-1462.57%
-654.47%
1746.04%

Addex Therapeutics Ltd Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-2
-2
-3
12
-1
-1
-1
-1
-1
Operating Cash Flow
-2
0
-2
-2
0
0
0
0
0
Investing Cash Flow
0
0
0
4
0
-
0
0
0
Financing Cash Flow
0
0
0
0
0
0
0
0
0
Change in Cash
-2
0
-2
2
0
0
0
0
0

Addex Therapeutics Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-3
-3
-1
-14
-12
-15
-20
-10
7
Operating Cash Flow
-2
-2
1
-9
-12
-14
-16
-7
-5
Investing Cash Flow
0
0
0
0
0
0
0
0
4
Financing Cash Flow
1
3
37
0
0
16
3
5
0
Change in Cash
-1
1
39
-10
-12
1
-13
-3
0

Global Institutional Holdings in Addex Therapeutics Ltd

Funds
Holdings
GAMMA Investing LLC
0.01%
SBI Securities Co Ltd
0%
Rhumbline Advisers
0.01%
SBI Securities Co Ltd
0%
UBS Group AG
0%
See all

Insights on Addex Therapeutics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -1.84M → -1.57M (in $), with an average increase of 16.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 121.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.3% return, outperforming this stock by 58.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 36.37K → 29.72K (in $), with an average decrease of 18.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ADXN stock has moved down by -14.6%

About Addex Therapeutics Ltd

addex therapeutics is pioneering discovery and development of an emerging class of oral small molecule drugs, called allosteric modulators, which can be exquisitely selective for their intended target and confer significant therapeutic advantages over conventional “orthosteric” small molecule or biological drugs. the company uses its proprietary discovery platform to address receptors and other proteins that have been undruggable for conventional drug discovery methods, including g-protein coupled receptors (gpcrs), receptor tyrosine kinases (rtks) and cytokine receptors, such as the tnf receptor superfamily. many such targets have been widely recognized as attractive for modulation of important diseases with unmet medical needs, but have remained inaccessible to small molecule drug discovery. the company’s two lead products are: dipraglurant (adx48621), an mglur5 negative allosteric modulator, or nam, which reduced parkinson’s disease levodopa-induced dyskinesia (pd-lid) in a phase ii
OrganisationAddex Therapeutics Ltd
HeadquartersChemin des Mines, 9, Geneva, Switzerland, 1202
IndustryHealth Technology
CEOMr. Timothy Mark Dyer
E-voting on sharesClick here to vote

Key Management of Addex Therapeutics Ltd

Name

Title

Mr. Timothy Mark Dyer

Co-Founder, CEO & Director

Dr. Roger G. Mills M.D.

Chief Medical Officer & Director

Mr. Lénaic Teyssédou

Head of Finance

Dr. Mikhail Kalinichev Ph.D.

Head of Translational Science

FAQs

What is Addex Therapeutics Ltd share price today?

Addex Therapeutics Ltd share price today is $5.72 as on at the close of the market. Addex Therapeutics Ltd share today touched a day high of $6.46 and a low of $5.72.

What is the 52 week high and 52 week low for Addex Therapeutics Ltd share?

Addex Therapeutics Ltd share touched a 52 week high of $12.05 on and a 52 week low of $5.57 on . Addex Therapeutics Ltd stock price today i.e. is closed at $5.72,which is 52.53% down from its 52 week high and 2.69% up from its 52 week low.

What is Addex Therapeutics Ltd's market capitalisation today?

Addex Therapeutics Ltd market capitalisation is $0.00T as on .

How to invest in Addex Therapeutics Ltd Stock (ADXN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Addex Therapeutics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Addex Therapeutics Ltd Shares that will get you 0.2622 shares as per Addex Therapeutics Ltd share price of $5.72 per share as on April 3, 2026 at 1:12 am IST.

What is the minimum amount required to buy Addex Therapeutics Ltd Stock (ADXN) from India?

Indian investors can start investing in Addex Therapeutics Ltd (ADXN) shares with as little as ₹92.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Addex Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Addex Therapeutics Ltd share’s latest price of $5.72 as on April 3, 2026 at 1:12 am IST, you will get 1.7483 shares of Addex Therapeutics Ltd. Learn more about fractional shares .

What are the returns that Addex Therapeutics Ltd has given to Indian investors in the last 5 years?

Addex Therapeutics Ltd stock has given -97.29% share price returns and 26.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?